Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

IASO-782 in Autoimmune Hematological Diseases

NCT06534021

Conditions
Autoimmune Diseases, Autoimmune Thrombocytopenia, Blood Coagulation Disorders, +17 more
Locations
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Institute of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06988488

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Yale New Haven Hospital-Smilow Cancer Center New Haven, Connecticut, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 22 locations
View Trial Details
Recruiting

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

NCT06528301

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +19 more
Locations
  • City of Hope Duarte, California, United States
  • The David and Etta Jonas Center for Cellular Therapy Chicago, Illinois, United States
  • Washington University School of Medicine/Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

NCT04953910

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • MD Anderson Houston, Texas, United States
  • Erebuni Medical Center Yerevan, Armenia
  • Hematology Center After Prof. R. Yeolyan (Adult Blood Disorders) Yerevan, Armenia
  • Hematology Center After Prof. R. Yeolyan (Clinic of Adults Oncology) Yerevan, Armenia
View all 22 locations
View Trial Details
Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

NCT04953897

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • MD Anderson Houston, Texas, United States
  • Erebuni Medical Center Yerevan, Armenia
  • Hematology Center After Prof. R. Yeolyan (Adult Blood Disorders) Yerevan, Armenia
  • Hematology Center After Prof. R. Yeolyan (Clinic of Adults Oncology) Yerevan, Armenia
View all 21 locations
View Trial Details
Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06297226

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 214) Los Angeles, California, United States
View all 52 locations
View Trial Details

Related conditions